P313 Steroid and opioid use among Crohn’s patients before and after initiation of ustekinumab

A goal of pharmaceutical treatment (tx) in CD is resolution of symptoms. Proxies for successful tx from administrative claims databases can provide insight into real-world drug effectiveness. Reductions in use of drugs associated with tx of Crohn-related symptoms may be a proxy for tx effectiveness. To examine the use of opioids and steroids in patients with CD before and after initiation of ustekinumab (UST). The analytic cohort was drawn from...